Pharmacology & therapeutics
- Label
- Pharmacology & therapeutics (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- NO sparks off chromatin: tales of a multifaceted epigenetic regulator (Articolo in rivista) (Prodotto della ricerca)
- Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- Biochemistry and pharmacology of endovanilloids (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies (Articolo in rivista) (Prodotto della ricerca)
- P2 receptor web: Complexity and fine-tuning. (Articolo in rivista) (Prodotto della ricerca)
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. (Articolo in rivista) (Prodotto della ricerca)
- ALS: Focus on purinergic signalling (Articolo in rivista) (Prodotto della ricerca)
- Toward the rational design of protein kinase CK2 inhibitors. (Articolo in rivista) (Prodotto della ricerca)
- Alternative label
- Pharmacol. ther. (literal)
- Pharmacology and therapeutics (literal)
- Pharmacology & therapeutics. (literal)
- Language
- eng (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn
- 0163-7258 (literal)
- Preferred label
- Pharmacology & therapeutics (literal)
- Publisher
- Elsevier. New York: USA (literal)
Incoming links:
- Rivista
- Biochemistry and pharmacology of endovanilloids (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Toward the rational design of protein kinase CK2 inhibitors. (Articolo in rivista) (Prodotto della ricerca)
- P2 receptor web: Complexity and fine-tuning. (Articolo in rivista) (Prodotto della ricerca)
- NO sparks off chromatin: tales of a multifaceted epigenetic regulator (Articolo in rivista) (Prodotto della ricerca)
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. (Articolo in rivista) (Prodotto della ricerca)
- Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- ALS: Focus on purinergic signalling (Articolo in rivista) (Prodotto della ricerca)
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies (Articolo in rivista) (Prodotto della ricerca)
